LAUSR

Neuroendocrine tumors (NETs), commonly called carcinoid tumors, are extremely rare and accounts for only 0.2% of all carcinoid and testicular neoplasms [1]. NETs can arise from neuroendocrine cells throughout the body, but mostly detected in the gastrointestinal tract and bronchopulmonary system. It can produce peptides that cause characteristic hormonal syndromes and may have an indolent or aggressive course. The diagnosis of these neoplasms is based mainly on the immunohistochemistry study. They have a good prognosis, with a 5-year overall and specific survival rates of 78.7% and 84.3%, respectively [2]. Whereas radical orchiectomy is the treatment of choice for testicular TETs, the current report will present atypical primary testicular tumor, which has been managed by excision of the testicular mass under ultrasound guidance, using excisional frozen biopsy, followed by orchiopexy. Up to knowledge, this case represents rarity of rarity; presents with primary infertility and managed by testicular preservation.